Biotech

Pebblebed invests in early-stage startups with a strong emphasis on technical insights. They look for businesses that can establish enduring competitive moats, such as brand loyalty, high switching costs, and user stickiness.

An early-stage firm investing in science-driven companies that operate at the intersection of AI and automation, helping drive forward transformative technologies.

A Boston-based VC firm supporting founders with early-stage and seed funding, dedicated to fostering both professional and personal growth in the entrepreneurs they back.

Focuses on breakthrough scientific startups, investing in transformative and innovative technologies that drive significant advances in their fields.

Realist Ventures invests in diverse teams creating modern solutions to biotech and software challenges, currently avoiding investments in food, consumer goods, and hardware.

A $50M fund investing in seed-stage startups deploying technology to revolutionize heavily regulated industries, enhancing both human and planetary health.

Rogue is a $60M early-stage fund investing in both deep tech innovations and founders at the nexus of technology and cultural change.

Helps daring founders grow legendary companies, from initial concept to IPO and beyond.

Backed by Max and Nellie Levchin, this fund partners with founders tackling complex, impactful challenges that require deep intellectual curiosity and scientific rigor.

Led by founders-turned-investors, this fund supports early-stage technical founders by providing initial capital while empowering them with control over company direction. They also run the SciFounder Fellowship for idea-stage entrepreneurs.

Finance-focused social impact venture capital fund aiming to create positive financial and social outcomes.

SOSV is a multi-stage venture capital firm that provides pre-seed startup development programs for founders with groundbreaking technologies.

Invests in visionary founders building a better future, helping them craft impactful stories that shape tomorrow.

Driven by the belief that healthy ecosystems—planet, people, and economy—are interconnected, they invest in startups tackling Climate, Health, and Economic Opportunity. Their philosophy is that anyone should have the chance to turn an idea into reality without barriers based on identity or origin.

Takeda’s venture arm supports digital health innovations aimed at enhancing patient outcomes and healthcare delivery.

Seeks out founders developing breakthrough technologies that have the potential to scale into transformational platforms.

An early-stage venture capital firm focused on empowering tech companies founded by women that are transforming industries.

A $37 million fund investing in seed and Series A stages for startups pursuing therapeutic breakthroughs targeting age-related diseases.

Backs rapidly scaling companies with a potential for large-scale global impact.

Tribe Capital, established in 2018, leverages product and data science to build unique companies, managing over $1.6B AUM.

Trailhead Capital is dedicated to mission-driven investments in the future of food and agriculture, striving for financial, societal, and ecological returns.

Founded in 2005, True Ventures has invested $3.8B across 350+ teams. They prioritize taking part in initial funding rounds and continuing support throughout a company’s journey, targeting substantial equity positions.

Two Sigma Ventures is an early-stage venture fund backing ambitious people to solve challenging problems and drive innovation.

Twine, led by Leshika Samarasinghe, supports early-stage teams tackling challenges in healthcare, climate, and financial empowerment, leveraging a targeted approach and a strong ecosystem of experts.

A cross-border early-stage firm connecting resources and networks from influential global markets to support startups’ growth.

A manifesto-driven venture fund that backs globally impactful disruptive companies.

$10M fund investing in Web3, AI, and Deep Science startups that focus on equitable, transparent, and beneficial wealth creation structures.

State-of-the-art lab facilities to help academic founders launch innovative biotech companies.

Wing invests at the earliest stages, often before a product or revenue, and continues supporting portfolio companies with strategic resources throughout their growth.

Focuses on helping seed-stage founders in their mission to improve human and planetary health.